{"schema_version":"1.0","canonical_url":"https://patentable.app/patents/US-11246882","patent":{"patent_number":"US-11246882","title":"Pharmaceutical composition for inhibiting resistance against anticancer drugs of patient suffering from ovarian cancer comprising NAG-1 inhibitor as active ingredient","assignee":null,"inventors":[],"filing_date":"2016-07-08T00:00:00.000Z","publication_date":"2022-02-15T00:00:00.000Z","cpc_codes":["C12Q","G01N","G01N","G01N","C12Q","C12Q","G01N","G01N"],"num_claims":3,"abstract":"A pharmaceutical composition includes an NAG-1 inhibitor as an active ingredient for inhibiting resistance against an anticancer drug of an ovarian cancer patient and a method of diagnosing prognosis of resistance against an anticancer drug of an ovarian cancer patient by using the NAG-1 inhibitor. It is found by controlling NAG-1 protein that NAG-1, which is overexpressed in an ovarian cancer patient and in an ovarian cancer stem cell having resistance against an anticancer drug, plays a key role in a chronic inflammatory reaction and resistance against an anticancer drug, and in this regard, NAG-1 can be used as a target gene for effective tumor therapy."},"analysis":{"summary":null,"layman_explanation":null,"technical_analysis":null,"business_analysis":null,"faqs":null,"topics":[],"tech_cluster":null},"seo":{"title":"Pharmaceutical composition for inhibiting resistance against anticancer drugs of patient suffering from ovarian cancer comprising NAG-1 inhibitor as active ingredient","description":"A pharmaceutical composition includes an NAG-1 inhibitor as an active ingredient for inhibiting resistance against an anticancer drug of an ovarian cancer patient and a method of diagnosing prognosis ","keywords":[]},"attribution":{"source":"Patentable","source_url":"https://patentable.app","canonical_url":"https://patentable.app/patents/US-11246882","license":"CC-BY-4.0-like","license_terms":"AI-generated analysis on this page (summary, layman_explanation, technical_analysis, business_analysis, faqs) may be reused with attribution and a visible link back to the canonical URL above. Patent abstracts, claims, and bibliographic data are USPTO public domain.","required_link":"https://patentable.app/patents/US-11246882","citation_suggestion":"Patentable. \"Pharmaceutical composition for inhibiting resistance against anticancer drugs of patient suffering from ovarian cancer comprising NAG-1 inhibitor as active ingredient\" (US-11246882). https://patentable.app/patents/US-11246882","copyright_holder":"Nomic Interactive Technology LLC"},"links":{"html":"https://patentable.app/patents/US-11246882","json":"https://patentable.app/api/llm-context/US-11246882","site":"https://patentable.app","llms_txt":"https://patentable.app/llms.txt"},"generated_at":"2026-05-30T09:36:10.709Z"}